Skip to main content
About Us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Our Approach
PDE4 Prodrug
Publications
Pipeline
Overview
PALI-2108
Investors & News
Overview
Press Releases
Events & Presentations
Analyst Coverage
SEC Filings
Corporate Governance
IR Resources
Stock Information
FAQs
Email Alerts
Contact
Publications
IBD Innovate 2024
|
Cambridge, MA
April 9–10, 2024
|
1 presentation
Advancing PALI-2108: Discovery to Strategic Positioning
View PDF
Crohn's & Colitis Congress 2024
|
Las Vegas, NV
January 25–27, 2024
|
1 poster
Local Bioactivation and Efficacy of PALI-2108: A Promising PDE4 Inhibitor Prodrug for Ulcerative Colitis Treatment
View PDF
Showing conferences 13–14 of 14
← Previous
1
2
3